Synthetic Data in Clinical Development: Enabling the Next Generation of Scientific Evidence
Thursday, January 28, 2027 at 4:10 PM to 4:40 PM · 30 min. (Europe/London)
AI in Drug Discovery Stage
Day 2 - Thursday 28th January
AIAI in Drug DiscoveryDrug Discovery
Information
- How close collaboration between industry and regulators is helping establish the principles, guidance, and trust needed for the responsible use of synthetic data in clinical development.
- The growing range of synthetic data applications across the drug development lifecycle, including evidence generation, extrapolation, trial optimisation, and support for hard-to-study patient populations.
- The business and patient impact of synthetic data: accelerating decision-making, improving efficiency, expanding access to evidence, and enabling new approaches that can ultimately help bring innovations to patients faster.
